Prof Dr. Devanshi Seth : Leading Researcher in Hepatology
Principal Scientist at Royal Prince Alfred Hospital, Australia
Congratulations, Prof Dr. Devanshi Seth, on winning the esteemed Best Researcher Award from Citation Awards! Your dedication, innovative research, and scholarly contributions have truly made a significant impact in your field. Your commitment to advancing knowledge and pushing the boundaries of research is commendable. Here’s to your continued success in shaping the future of academia and making invaluable contributions to your field. Well done!🌿
Prof Dr. Devanshi Seth an Principal Scientist at Royal Prince Alfred Hospital, Australia, stands as a distinguished academic and researcher in the domain of Biochemistry, Genetics and Molecular Biology. Holding a PhD in Hepatology from Royal Prince Alfred Hospital, their professional journey exemplifies dedication and expertise.🧑🔬
Current Positions:
Principal Scientist, Edith Collins Centre (Translational Research in Alcohol Drugs and Toxicology), Sydney Local Health District (SLHD), and Drug Health Services, Royal Prince Alfred Hospital (RPAH).
Associate Faculty & Head, Alcoholic Liver Disease Program, Centenary Institute of Cancer Medicine and Cell Biology.
Clinical Professor, Faculty of Medicine and Health, the University of Sydney (USYD).
Honorary Visiting Professor, Faculty of Science, University Technology of Sydney (UTS).👨⚕️
Professional Profiles:
Scopus Profile
ORCID Profile
LinkedIn
Employment History:
Edith Collins Centre Translational Research in Alcohol Drugs and Toxicology, Sydney Local Health District (SLHD), Aus Centenary Institute, The University of Sydney, Australia
Education:
MPH in University of Sydney, Australia, 2009
PhD in Punjab Agricultural University (PAU), India
Background:
Awarded the highly competitive and prestigious Indian Commonwealth Scholarship for post-doctoral studies at Cambridge, UK, in 1987.
Headhunted by a biotech company in Perth, Australia, in 1990, leading their Corporate Research & Development and Marketing divisions for over six years.
Returned to academia, focusing on cancer research before expanding into the alcohol-liver research field from 2001 to the present.
Areas of Specialization:
Botany
Plant Virology
Genetics
Small Business Enterprise
Public Health
Awards and Recognition 2023:
Finalist, 2023 Research Australia Health & Medical Research Awards – Health Services Award sponsored by NSW Government
Finalist, Women’s Agenda Leadership Awards ‘Science Category’ 2023
Peer Reviewer & Academic Engagements:
Citations: 2222 (as of Oct 2023)
h-index: 26 (All), 26 (Since 2018)
i10-index: 35 (All), 35 (Since 2018)
Publications: 48 documents indexed in Scopus
Current research program:
Established the Alcohol-related Liver Disease (ALD) Research Program in Australia in 2008.
Founded and leads the multinational GenomALC Consortium.
Two grants (2010, 2018) from the prestigious National Institutes of Health (NIH)/National Institute on Alcohol Abuse & Alcoholism (NIAAA), USA.
Led an international grant through the Australia India Strategic Research Fund (2013-2016) on liver regeneration and angiogenesis.
Attracted national and international funding exceeding >$5.5 million in the last decade.
Research Focus:
Genetics, Biotechnology, Host-parasite genetics, Host-parasite genetics, Industrial Fungal, Biotechnology, Cancer biology, Childhood leukemia, Alcohol & Liver genetics, Alcohol & Liver genetics, Alcoholic Liver Disease Research Program.
Selective Publications (JOURNALS):
MicroRNAs Signature Set Identifies Heavy Drinkers with Alcohol-associated Cirrhosis from those Without Liver Injury.Biology 2023 (ahead of print).
Investigating the role of lipid genes in liver disease using fatty liver models of alcohol and high fat in zebrafish (Danio rerio). Liver International 2023, 43:2455-2468.
Validation of the aMAP score to predict hepatocellular carcinoma development in a cohort of alcohol-related cirrhosis patients. Liver Cancer Inter 2022, 3: 99-104 .
All-cause and liver-related mortality risk factors in excessive drinkers: Analysis of data from the UK biobank. Alcohol Clin Exp Res 2022, 46(12):2245-2257.
External validation of a genetic risk score that predicts development of alcohol-related cirrhosis. Hepatology 2022, 77(6):1721-1722.
Urinary versus serum microRNAs in human oxalic acid poisoning: Contrasting signals and performance. Toxicology Letters 2020, 334:21-6.
Online interventions for people hospitalized for deliberate self-harm and problematic alcohol use: Lessons learned from the iiAIM trial. Bulletin of the Menninger Clinic 2021, 85 (2):123-142
the GenomALC Consortium.Novel association of Faf2 with risk of alcohol-related cirrhosis in high-risk drinkers: growing evidence of lipid genetics in cirrhosis(virtual poster). Australian Gastroenterology Week-Gastroenterological Society of Australia 2020, 21-30th Nov 2020.
Contribution of common SNPs in explaining genetic variability in alcoholic cirrhosis. Oral presentation in Symposium ‘Genetics/genomics in alcohol induced liver injury – 21-24th Sep 2019.
Alcohol on fat: worse consequences for liver injury. Invited presentation for symposium ‘Second hits in alcohol-related organ damage’. European Society for Biomedical Research on Alcoholism (ESBRA) Society meeting, Lille 21-24th Sep 2019.